The main mutation responsible for the fragile X syndrome is the expansion of an untranslated CGG repeat in the first exon of the FMR1 gene, associated with the hypermethylation of the proximal CpG island and the CGG repeat region, and repression of transcription of FMR1. Fragile X syndrome mosaicism has been described as the coexistence of the full mutation and the premutation. We present here two cases of mosaicism for the full mutation in the FMR1 gene and deletions involving the CGG repeat region. In one case the deletion removed 113 bp proximal to the CGG repeat and part of the repeat itself, leaving 30 pure repeats, and representing 17% of lymphocytes of the patient. The 5' breakpoint of this deletion falls outside the putative hotspot for deletions in the CGG region of FMR1. In the second case the deleted region only involved the CGG sequence (leaving 15 pure repeats), with normal sequences flanking the repeat; this deleted ("normal") FMR1 was estimated to be in about 31% of blood lymphocytes. This second case can be considered a true regression of the CGG FMR1 expansion to a normal sized allele, although in mosaic form. (J Med Genet 1996;33:338-340) Southern blot analysis with probe StB 12.3 after double digestion with EcoRI and EagI in patient 1 showed a 6&1-6-7 kb smear corresponding to the FMR1 full mutation, and an additional fragment of 26 kb (instead of the expected 2-8 kb EcoRI/EagI fragment in normal subjects ( fig IA) . Densitometric analysis showed that 17% of the patient's blood lymphocytes had the 26 kb fragment. Analysis of the family members showed that the mother and the maternal grandfather had premutations (about 156 and 112 CGG repeats, respectively). To determine the molecular basis of the deleted fragment, we performed PCR analysis using primers flanking the CGG repeat. Whereas primers P12 and P2 (5'-TTGTA- 
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(J Med Genet 1996;33: [338] [339] [340] Southern blot analysis with probe StB 12.3 after double digestion with EcoRI and EagI in patient 1 showed a 6&1-6-7 kb smear corresponding to the FMR1 full mutation, and an additional fragment of 26 kb (instead of the expected Both patients with the classical Martin syndrome phenotype show the coexisten< the full mutated FMR1 gene and a del or a "normal" FMR1 gene. Several cast mosaicism for the full mutation and delei within the CGG repeat region of FMR1 been described recently.5`7`Although our patients apparently show similarities to t previously described, the molecular c acterisation indicated several differences.
The first case (patient 1) differs from the cases described previously67 in that the dele includes the Chi-like sequence, located 5' to the deletions described by de Graaff et al, 6 and the deletion conserved part of the CGG repeats (30 pure repeats). A further patient mosaic for the full mutation and a 660 bp deletion, including the CGG repeat, has recently been 320 described.f In this case and in our patient 1, the 5' endpoint was located outside the Chilike sequence, making its involvement in the mechanism causing the deletions questionable (fig 3) . Other mutations in this region include a 1 6 kb germline deletion involving the promoter of FMR1 and part of the CGG repeat" and a YAC clone derived from a fragile X patient with about 350 CGG repeats that gene.
showed a deletion of 43 patients, we expect them to have detectable t the levels of FMR1 mRNA and FMRP. However, any the postulated levels of between 31% and 50% Some of FMRP in these patients might not be enough PCR to prevent the clinical abnormalities of the tpeat fragile X syndrome that they have. This is in tively agreement with a recent report that shows a uduct wide range of FMRP levels (between 10% allele and 60%) in fragile X syndrome males with ional mosaicism for the full mutation and the prethat mutation.'3 A major difference between the llele. mosaic males and these two cases is that the allele repeat length is normal. Finally, we do not nGG know the proportions or the existence of this type of mosaicism in other tissues from these -Bell cases. The presence of the "normal" allele at ce of relatively high levels in these mosaic fragile X leted patients shows that the full mutation and its es of methylation is the determinant of the phenotions type, regardless of the presence of a normal have copy of the gene. 
